Image Analysis & Diagnosis

Visual Findings Across All Images

Most Likely Diagnosis: Tinea Corporis (Ringworm)

"Tinea corporis manifests as well-demarcated, annular, pruritic, scaly lesions that undergo central clearing."

• Harrison's Principles of Internal Medicine, 22E

"This form of ringworm is characterized by one or more circular, sharply circumscribed, slightly erythematous, dry, scaly patches. An advancing scaling edge is usually prominent. Progressive central clearing produces annular outlines."

• Andrews' Diseases of the Skin

Causative Fungi (Most Likely Species)

1. Trichophyton rubrum - Most common worldwide; causes chronic, mildly inflammatory ringworm
2. Trichophyton mentagrophytes - Can cause more inflammatory lesions with vesicles (matches some of the images showing vesicular borders); also linked to Southeast Asian zoonotic strains
3. Microsporum canis - Common when infection came from a cat or dog; typically multiple smaller lesions

Why This is Fungal and Not Something Else

Recommended Diagnosis Confirmation

Treatment

• Topical antifungals (2-4 weeks, twice daily): Terbinafine (Lamisil), Clotrimazole, Miconazole, Ketoconazole, or Econazole cream
• Terbinafine is particularly effective and can be used once daily
• If widespread or unresponsive to topicals: oral antifungals (Terbinafine 250 mg/day x 2-4 weeks, or Fluconazole)

• Do NOT apply topical steroid creams (hydrocortisone etc.) - this converts it to Tinea Incognita - the rash loses its typical ring appearance but the fungal infection worsens and spreads underneath
• Avoid sharing towels/clothing; keep the area dry
• Check household pets for similar lesions (if M. canis is suspected)

Disclaimer: This analysis is for educational purposes only. Please see a dermatologist or physician for official diagnosis and prescription treatment. A simple in-office KOH test can confirm the diagnosis in minutes.

Why Itraconazole & Ketoconazole Failed

Resistance Profile of T. indotineae

• JAAD 2024 review (Khurana et al.): "T. indotineae shows alarmingly high rates of mutations in the squalene epoxidase gene... prolonged treatment durations are required to achieve cure with itraconazole."

What Should Be Done Now

Step 1 - Confirm the organism

• KOH scraping from the active border (not the center)
• Fungal culture - growth within 1-2 weeks
• If available: ITS sequencing or MALDI-TOF to confirm T. indotineae (standard lab methods cannot distinguish it from T. mentagrophytes)
• Antifungal susceptibility testing (MIC) is the gold standard to guide therapy

Step 2 - Stop using corticosteroid-containing creams

Step 3 - Revised Treatment Options (Evidence-Based)

• Oral Itraconazole 200 mg/day for 12-16 weeks (much longer than the standard 2-4 weeks)
• Some experts use 200 mg twice daily for severe/refractory cases
• IADVL (Indian Association of Dermatology) recommends higher doses and extended durations
• Combine with a topical agent: Ciclopirox olamine 1% cream or Luliconazole 1% cream (apply BID to lesions)

• Oral Voriconazole or Oral Posaconazole - newer triazoles; generally susceptible
• Oral Terbinafine at high dose (500 mg/day) - may still work in cases where the squalene epoxidase mutation is partial
• Anidulafungin IV has been used in severe refractory hospital cases (Singapore 2025 CDC case)

• Luliconazole 1% (superior skin penetration, higher fungicidal activity)
• Ciclopirox olamine 1%
• Efinaconazole (newer)
• Avoid: clotrimazole, miconazole alone (weaker activity)

Important Lifestyle & Hygiene Measures

1. Wash and dry affected area thoroughly - fungi thrive in moisture
2. Wear loose, cotton, breathable clothing
3. Do not share towels, razors, or clothing
4. Wash bed linen and clothes in hot water (>60°C) during treatment
5. Treat family members/contacts who may be infected (common source of re-infection)
6. Check pets for skin lesions

Key Takeaway

1. See a dermatologist who can order fungal culture + susceptibility testing
2. Request extended high-dose itraconazole (12-16 weeks) + topical luliconazole
3. If still failing, escalate to voriconazole or posaconazole

Disclaimer: This is educational information only. Prescription antifungals, especially at higher doses and extended durations, require monitoring for liver toxicity (LFTs) and drug interactions. Please see a dermatologist or physician for proper management.

Topical Antifungal Options for Resistant Tinea

Why Standard Topicals Fail

• Point mutations in the squalene epoxidase (SQLE) gene → terbinafine resistance
• Elevated minimum inhibitory concentrations (MICs) against azole class drugs
• Prior misuse of steroid-containing combination creams (e.g., clotrimazole + betamethasone) that suppress local immunity and drive resistance

Ranked Topical Agents by Effectiveness Against Resistant Strains

Tier 1 - Best Activity (Lowest MICs)

Tier 2 - Useful Alternatives

Tier 3 - Inadequate Alone (Use Only as Add-On)

• Clotrimazole, Miconazole, Ketoconazole topicals - often insufficient MIC coverage alone against resistant T. indotineae but can supplement oral therapy

Evidence-Backed Combination Strategies

Combination 1 - Most Supported

• PMC 2025 case review: Thakur et al. - disseminated T. indotineae cured in 2 months with this exact combination
• Luliconazole handles the surface/stratum corneum while itraconazole handles deeper tissue and provides systemic coverage

Combination 2

• Ciclopirox is particularly valuable because its mechanism is completely independent of azoles and terbinafine - no cross-resistance
• Ciclopirox had the lowest resistance rate (7.5%) in a 2025 Assam study testing 80 dermatophyte isolates against 6 antifungals

Combination 3 - For Terbinafine-Susceptible Strains

• Case report: T. indotineae with nail/skin involvement regressed after 12 weeks with this combination

What NOT to Combine

• Oral terbinafine + oral itraconazole - no additive benefit, increases side effects
• Any topical containing corticosteroids - strictly avoid; turns tinea into tinea incognito and drives further resistance

Resistance Rates Compared Across Topical-Relevant Drugs (2025 data)

Practical Topical Protocol Summary

1. Stop all steroid-containing creams immediately
2. Start Luliconazole 1% cream once daily to all lesions (extend 2-3 cm beyond border)
3. Alternate or add Ciclopirox olamine 1% twice daily (especially effective if steroid abuse suspected)
4. Combine with oral itraconazole at higher dose (200-400 mg/day) for 12-16 weeks - not the standard 2-4 week course
5. Consider SUBA-itraconazole (super-bioavailable formulation) if standard itraconazole absorption is erratic
6. If still failing after 12+ weeks: refer for fungal culture + MIC testing and consider voriconazole/posaconazole

Key references:

• Khurana et al., JAAD 2024 - T. indotineae therapeutic updates [PMID: 38574764]
• Gupta et al., Expert Rev Anti Infect Ther 2024 - Antifungal resistance strategies [PMID: 39114868]
• Gupta et al., Expert Opin Pharmacother 2025 - Recalcitrant dermatophytosis management [PMID: 41417273]
• Caplan et al., Am Fam Physician 2025 - Diagnosis and management of tinea [PMID: 41118183]

Disclaimer: These are evidence-based educational summaries. Actual prescribing and treatment duration must be decided by a qualified dermatologist based on culture results, susceptibility testing, and individual patient factors including liver function.